407 related articles for article (PubMed ID: 7748811)
1. Androgens induce divergent proliferative responses in human breast cancer cell lines.
Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094
[TBL] [Abstract][Full Text] [Related]
4. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
5. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
[TBL] [Abstract][Full Text] [Related]
6. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
[TBL] [Abstract][Full Text] [Related]
7. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
Olea N; Sakabe K; Soto AM; Sonnenschein C
Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
[TBL] [Abstract][Full Text] [Related]
8. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Poulin R; Baker D; Labrie F
Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Hofbauer LC; Hicok KC; Khosla S
J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
[TBL] [Abstract][Full Text] [Related]
10. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer: from estrogen to androgen receptor.
Andò S; De Amicis F; Rago V; Carpino A; Maggiolini M; Panno ML; Lanzino M
Mol Cell Endocrinol; 2002 Jul; 193(1-2):121-8. PubMed ID: 12161011
[TBL] [Abstract][Full Text] [Related]
12. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression.
Hall RE; Birrell SN; Tilley WD; Sutherland RL
Eur J Cancer; 1994; 30A(4):484-90. PubMed ID: 8018407
[TBL] [Abstract][Full Text] [Related]
13. Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T).
Marugo M; Bernasconi D; Miglietta L; Fazzuoli L; Ravera F; Cassulo S; Giordano G
J Steroid Biochem Mol Biol; 1992 Jun; 42(5):547-54. PubMed ID: 1616884
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action.
Di Monaco M; Leonardi L; Gatto V; Gallo M; Brignardello E; Boccuzzi G
Anticancer Res; 1995; 15(6B):2581-4. PubMed ID: 8669827
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.
Ortmann J; Prifti S; Bohlmann MK; Rehberger-Schneider S; Strowitzki T; Rabe T
Gynecol Endocrinol; 2002 Apr; 16(2):113-20. PubMed ID: 12012621
[TBL] [Abstract][Full Text] [Related]
17. Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells.
Ormandy CJ; Clarke CL; Kelly PA; Sutherland RL
Int J Cancer; 1992 Mar; 50(5):777-82. PubMed ID: 1544711
[TBL] [Abstract][Full Text] [Related]
18. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.
Lin HY; Sun M; Lin C; Tang HY; London D; Shih A; Davis FB; Davis PJ
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):182-8. PubMed ID: 19159686
[TBL] [Abstract][Full Text] [Related]
19. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
[TBL] [Abstract][Full Text] [Related]
20. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
Moore NL; Buchanan G; Harris JM; Selth LA; Bianco-Miotto T; Hanson AR; Birrell SN; Butler LM; Hickey TE; Tilley WD
Endocr Relat Cancer; 2012 Aug; 19(4):599-613. PubMed ID: 22719059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
